OMIX007346

1Summary
Title Dexmedetomidine Decreases Cerebral Hyperperfusion Incidence Following Carotid Stenting: A Double-blind Randomized Controlled Trial
Description The matrix was imported in R to carry out Principle Component Analysis (PCA) to observe the overall distribution among the samples and the stability of the whole analysis process. Orthogonal Partial Least-Squares-Discriminant Analysis (OPLS-DA) and Partial Least-Squares-Discriminant Analysis (PLS-DA) were utilized to distinguish the metabolites that differ between groups. To prevent overfitting, 7-fold cross-validation and 200 Response Permutation Testing (RPT) were used to evaluate the quality of the model. Variable Importance of Projection (VIP) values obtained from the OPLS-DA model were used to rank the overall contribution of each variable to group discrimination. A two-tailed Students T-test was further used to verify whether the metabolites of difference between groups were significant. Differential metabolites were selected with VIP values greater than 1.0 and p-values less than 0.05.
Organism Homo sapiens
Data Type Metabolome Data by Mass Spectrometry (MS)
Data Accessibility Open-access
BioProject PRJCA030028
Release Date 2024-09-11
Submitter Enqiang Chang (changenqiang@zzu.edu.cn)
Organization People's Hospital of Zhengzhou
Submission Date 2024-09-10
2Files & Download

HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).

File ID File Title Number/Samples File Type File Size File Suffix Download
OMIX007346-01 raw data 16 Metabolome Data by Mass Spectrometry (MS) 90.5 MB zip
3Relevant Publications
Paper Title Journal Name Publish Time Accession Citing Type
Dexmedetomidine decreases cerebral hyperperfusion incidence following carotid stenting: A double-blind, randomized controlled trial Med 2024-10 OMIX007346 Deposit

View All Released Data of OMIX